Robert Lawrence Brainin
CIK: 0002088015
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CHAMPIONS ONCOLOGY, INC.
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Jul 16, 2025CSBR
CHAMPIONS ONCOLOGY, INC.
Award(A)DirectOption to purchase Common Stock
225K shares at avg. $7.80- - Jul 16, 2025CSBR
CHAMPIONS ONCOLOGY, INC.
Award(A)DirectOption to purchase Common Stock
62.5K shares at avg. $7.80- - Jul 16, 2025CSBR
CHAMPIONS ONCOLOGY, INC.
Award(A)DirectOption to purchase Common Stock
62.5K shares at avg. $7.80- - Jul 16, 2025CSBR
CHAMPIONS ONCOLOGY, INC.
Award(A)DirectOption to purchase Common Stock
150K shares at avg. $7.80- - Jul 16, 2025CSBR
CHAMPIONS ONCOLOGY, INC.
Award(A)DirectOption to purchase Common Stock
100K shares at avg. $7.80- - Jul 16, 2025CSBR
CHAMPIONS ONCOLOGY, INC.
Award(A)DirectOption to purchase Common Stock
100K shares at avg. $7.80- - Nov 12, 2024CSBR
CHAMPIONS ONCOLOGY, INC.
Award(A)DirectOption to purchase Common Stock
23K shares at avg. $4.64- - Nov 3, 2023CSBR
CHAMPIONS ONCOLOGY, INC.
Award(A)DirectOption to purchase Common Stock
19.1K shares at avg. $5.51- - Nov 1, 2022CSBR
CHAMPIONS ONCOLOGY, INC.
Award(A)DirectOption to purchase Common Stock
14.1K shares at avg. $7.00- - Nov 5, 2021CSBR
CHAMPIONS ONCOLOGY, INC.
Award(A)DirectOption to purchase Common Stock
9.9K shares at avg. $10.10-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 16, 2025 | CSBR CHAMPIONS ONCOLOGY, INC. | Award(A) Option to purchase Common Stock | 225,000 | $7.80 | - | Direct |
| Jul 16, 2025 | CSBR CHAMPIONS ONCOLOGY, INC. | Award(A) Option to purchase Common Stock | 62,500 | $7.80 | - | Direct |
| Jul 16, 2025 | CSBR CHAMPIONS ONCOLOGY, INC. | Award(A) Option to purchase Common Stock | 62,500 | $7.80 | - | Direct |
| Jul 16, 2025 | CSBR CHAMPIONS ONCOLOGY, INC. | Award(A) Option to purchase Common Stock | 150,000 | $7.80 | - | Direct |
| Jul 16, 2025 | CSBR CHAMPIONS ONCOLOGY, INC. | Award(A) Option to purchase Common Stock | 100,000 | $7.80 | - | Direct |
| Jul 16, 2025 | CSBR CHAMPIONS ONCOLOGY, INC. | Award(A) Option to purchase Common Stock | 100,000 | $7.80 | - | Direct |
| Nov 12, 2024 | CSBR CHAMPIONS ONCOLOGY, INC. | Award(A) Option to purchase Common Stock | 23,030 | $4.64 | - | Direct |
| Nov 3, 2023 | CSBR CHAMPIONS ONCOLOGY, INC. | Award(A) Option to purchase Common Stock | 19,070 | $5.51 | - | Direct |
| Nov 1, 2022 | CSBR CHAMPIONS ONCOLOGY, INC. | Award(A) Option to purchase Common Stock | 14,130 | $7.00 | - | Direct |
| Nov 5, 2021 | CSBR CHAMPIONS ONCOLOGY, INC. | Award(A) Option to purchase Common Stock | 9,901 | $10.10 | - | Direct |
1-10 of 10 transactions
About Brainin Robert Lawrence
Brainin Robert Lawrence (SEC CIK 0002088015) files insider reports with the SEC as Director of CHAMPIONS ONCOLOGY, INC. (CSBR).
Signal8 holds 3 ownership filings by Brainin Robert Lawrence (1 Form 3, 2 Form 4), filed between Jan 16, 2026 and Jan 30, 2026. Those filings report 10 transactions, from Nov 5, 2021 to Jul 16, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Brainin Robert Lawrence's filings is in HACKENSACK, NJ.
Recent filings by Brainin Robert Lawrence
- Jul 16, 2025: Grants or awards of CSBR derivative securities (6 lines, Form 4, code A).
- Nov 12, 2024: Grant or award of CSBR derivative securities (Form 4, code A).
- Nov 3, 2023: Grant or award of CSBR derivative securities (Form 4, code A).
- Nov 1, 2022: Grant or award of CSBR derivative securities (Form 4, code A).
- Nov 5, 2021: Grant or award of CSBR derivative securities (Form 4, code A).
Other insiders filing for CHAMPIONS ONCOLOGY, INC. (CSBR)
- ACKERMAN JOEL, Director
- Breitfeld Philip P., Director
- SIDRANSKY DAVID, Director
- Mendelson Daniel Newman, Director
- TOBIN SCOTT R, Director